Definitive Contract 140D0426C0010
Award Date 3/2/26
Potential Completion Date 3/1/28
Potential Value $600K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02140, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This federal contract award is for the development of GB13, a novel glioblastoma therapy, under the Small Business Innovation Research (SBIR) Phase I program. The contract was awarded by the National Cancer Institute (NCI), a civilian agency, to Targepeutics, Inc. for $199,785.00. The contract has a firm fixed-price type and an ultimate completion date of December 31, 2012. This contract award is set aside for total small business participation.</p>
- The National Institutes of Health has awarded a $593,800 firm fixed-price Definitive Contract to Memsel Inc., a small disadvantaged business manufacturer based in Fort Worth, Texas, under the Small Business Innovation Research (SBIR) program. The contract, set aside for small businesses with an ultimate completion date of March 1, 2027, supports Topic 5 research focused on precision brain targeting through non-invasive delivery systems. This award aligns with Memsel Inc.'s demonstrated expertise...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...
- Biosensics LLC has been awarded a $325,000 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct research and development activities aligned with the agency's goals. Specifically, the contract calls for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, as outlined in NIH and CDC Solicitation A Solicitation of the National Institutes of...
- This is a $849,987.00 federal contract award to Soterix Medical, Inc., a small business manufacturer of medical devices and equipment focused on non-invasive neuromodulation technologies, for the "Advancing and Validating Galvanic Induced Disorientation Simulation Trainer (GIST)" project. The contract was awarded by the National Aeronautics and Space Administration (NASA) Shared Services Center under the Small Business Innovation Research (SBIR) Program Phase II. The contract is a...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Advanced Silicon Group, Inc., a woman-owned small business. The contract, valued at $400,000.00, is for research and development of a biosensor prototype that can detect drugs in postmortem blood samples using coupled acoustical wave micropillar technology. The contract is a firm fixed-price definitive contract with a completion date of...
- This is a $1,997,803 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc., a small business manufacturer of specialized biomedical research equipment and tools. The contract is for the topic "Integrated Imaging and Molecular Analysis of Glioblastoma Using SCOPE SEQ on the Air Flow" and has a total small business set-aside designation. The contract will support...
- <p>The National Institutes of Health National Institute on Aging awarded Nanode Therapeutics, Inc. a $496,150.30 firm fixed price Small Business Innovation Research Program Phase I contract to develop a Novel Non-Viral Nanoparticles Gene Delivery System for Alzheimer's Disease Gene Therapy. The work will be performed in Barrington, Rhode Island over a one year period ending September 29, 2023. The contract was awarded as a total small business set aside.</p>
- This is a $355,000.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to Petri Bio Inc., a small business, under the Small Business Innovation Research (SBIR) Phase I program. The contract is for the development of engineered microbial therapeutics for the treatment of heritable forms of glioma, a type of brain cancer. The work is focused on demonstrating technical feasibility and proof-of-concept for this therapeutic technology....
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Mental Health (NIMH) to Giner Inc., a small business research and development firm based in Boston. The contract, valued at $306,499.12, is for the development of point-of-care HIV viral load and drug adherence assays. This aligns with NIMH's mission to advance research on mental health and HIV/AIDS. The contract was set aside for small businesses and is part of the broader DHHS SBIR/STTR...